Scott L. Pomeroy

Affiliations: 
Neurology Harvard Medical School - Boston Children's Hospital 
Area:
embryonal brain tumors, cell proliferation and differentiation
Google:
"Scott Pomeroy"
Mean distance: 13.48 (cluster 11)
 
SNBCP
Cross-listing:

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

McArthur JC, Augustine EF, Carmichael ST, et al. (2023) Recognizing and responding to the needs of future child and adult neurology care through the evolution of residency training. Annals of Neurology
Maynard R, Poore B, Hanaford AR, et al. (2021) TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma. Cancer Letters
Bhattacharya D, Pomeroy SL, Pomeranz Krummel DA, et al. (2020) Epigenetics and survivorship in pediatric brain tumor patients. Journal of Neuro-Oncology
Li BK, Vasiljevic A, Dufour C, et al. (2019) Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study. Acta Neuropathologica
Zhang L, He X, Liu X, et al. (2019) Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse. Cancer Cell
Hovestadt V, Smith KS, Bihannic L, et al. (2019) Resolving medulloblastoma cellular architecture by single-cell genomics. Nature
Bihannic L, Hovestadt V, Smith K, et al. (2019) PDTM-32. RESOLVING MEDULLOBLASTOMA CELLULAR ARCHITECTURE BY SINGLE-CELL GENOMICS Neuro-Oncology. 21: vi194-vi194
Archer TC, Ehrenberger T, Mundt F, et al. (2018) Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups. Cancer Cell. 34: 396-410.e8
Clark AR, Calligaris D, Regan MS, et al. (2018) Rapid discrimination of pediatric brain tumors by mass spectrometry imaging. Journal of Neuro-Oncology
Waszak SM, Northcott PA, Buchhalter I, et al. (2018) Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. The Lancet. Oncology
See more...